Funder
Natural Science Foundation of Fujian Province
Fujian Medical Innovation Project
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference54 articles.
1. Dai H, Zhang Q, Much AA, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the global burden of disease study 2017. Eur Heart J Qual Care Clin Outcomes. 2020; https://doi.org/10.1093/ehjqcco/qcaa061.
2. Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A. The epidemiology of atrial fibrillation and stroke. Cardiol Clin. 2016; https://doi.org/10.1016/j.ccl.2015.12.002.
3. Members AF, Kirchhof P, Benussi S, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESCEndorsed by the European stroke organisation (ESO). Eur Heart J. 2016;74(12):1359.
4. Bell RG, Matschiner JT. Warfarin and the inhibition of vitamin K activity by an oxide metabolite. Nature. 1972; https://doi.org/10.1038/237032a0.
5. Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol. 2011. https://doi.org/10.1111/j.1365-2141.2011.08753.x.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献